A citation-based method for searching scientific literature

Matthew Behr, Jing Zhou, Bing Xu, Hongwei Zhang. Acta Pharm Sin B 2021
Times Cited: 19







List of co-cited articles
180 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
42

Delivering CRISPR: a review of the challenges and approaches.
Christopher A Lino, Jason C Harper, James P Carney, Jerilyn A Timlin. Drug Deliv 2018
396
36

Identification of preexisting adaptive immunity to Cas9 proteins in humans.
Carsten T Charlesworth, Priyanka S Deshpande, Daniel P Dever, Joab Camarena, Viktor T Lemgart, M Kyle Cromer, Christopher A Vakulskas, Michael A Collingwood, Liyang Zhang, Nicole M Bode,[...]. Nat Med 2019
378
31


CRISPR-Cas9 Structures and Mechanisms.
Fuguo Jiang, Jennifer A Doudna. Annu Rev Biophys 2017
636
26

RNA-guided human genome engineering via Cas9.
Prashant Mali, Luhan Yang, Kevin M Esvelt, John Aach, Marc Guell, James E DiCarlo, Julie E Norville, George M Church. Science 2013
26

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.
Fathema Uddin, Charles M Rudin, Triparna Sen. Front Oncol 2020
65
26

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Danny Wilbie, Johanna Walther, Enrico Mastrobattista. Acc Chem Res 2019
94
26

A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.
Jonathan D Finn, Amy Rhoden Smith, Mihir C Patel, Lucinda Shaw, Madeleine R Youniss, Jane van Heteren, Tanner Dirstine, Corey Ciullo, Reynald Lescarbeau, Jessica Seitzer,[...]. Cell Rep 2018
296
26

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.
Julian D Gillmore, Ed Gane, Jorg Taubel, Justin Kao, Marianna Fontana, Michael L Maitland, Jessica Seitzer, Daniel O'Connell, Kathryn R Walsh, Kristy Wood,[...]. N Engl J Med 2021
219
26

Genome editing. The new frontier of genome engineering with CRISPR-Cas9.
Jennifer A Doudna, Emmanuelle Charpentier. Science 2014
26

CRISPR-Cas systems for editing, regulating and targeting genomes.
Jeffry D Sander, J Keith Joung. Nat Biotechnol 2014
26

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering.
Thomas Gaj, Charles A Gersbach, Carlos F Barbas. Trends Biotechnol 2013
21

CRISPR-engineered T cells in patients with refractory cancer.
Edward A Stadtmauer, Joseph A Fraietta, Megan M Davis, Adam D Cohen, Kristy L Weber, Eric Lancaster, Patricia A Mangan, Irina Kulikovskaya, Minnal Gupta, Fang Chen,[...]. Science 2020
496
21

CRISPR-Cas9 DNA Base-Editing and Prime-Editing.
Ariel Kantor, Michelle E McClements, Robert E MacLaren. Int J Mol Sci 2020
71
21

Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting.
Seung Min Kim, Yoosoo Yang, Seung Ja Oh, Yeonsun Hong, Minkoo Seo, Mihue Jang. J Control Release 2017
182
21

Search-and-replace genome editing without double-strand breaks or donor DNA.
Andrew V Anzalone, Peyton B Randolph, Jessie R Davis, Alexander A Sousa, Luke W Koblan, Jonathan M Levy, Peter J Chen, Christopher Wilson, Gregory A Newby, Aditya Raguram,[...]. Nature 2019
21

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair.
Kunwoo Lee, Michael Conboy, Hyo Min Park, Fuguo Jiang, Hyun Jin Kim, Mark A Dewitt, Vanessa A Mackley, Kevin Chang, Anirudh Rao, Colin Skinner,[...]. Nat Biomed Eng 2017
352
21

Rational designs of in vivo CRISPR-Cas delivery systems.
Cong-Fei Xu, Guo-Jun Chen, Ying-Li Luo, Yue Zhang, Gui Zhao, Zi-Dong Lu, Anna Czarna, Zhen Gu, Jun Wang. Adv Drug Deliv Rev 2021
52
21

A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.
Guojun Chen, Amr A Abdeen, Yuyuan Wang, Pawan K Shahi, Samantha Robertson, Ruosen Xie, Masatoshi Suzuki, Bikash R Pattnaik, Krishanu Saha, Shaoqin Gong. Nat Nanotechnol 2019
111
21

CRISPR provides acquired resistance against viruses in prokaryotes.
Rodolphe Barrangou, Christophe Fremaux, Hélène Deveau, Melissa Richards, Patrick Boyaval, Sylvain Moineau, Dennis A Romero, Philippe Horvath. Science 2007
21

Development and applications of CRISPR-Cas9 for genome engineering.
Patrick D Hsu, Eric S Lander, Feng Zhang. Cell 2014
15

Delivery of CRISPR/Cas9 for therapeutic genome editing.
Xiaojie Xu, Tao Wan, Huhu Xin, Da Li, Hongming Pan, Jun Wu, Yuan Ping. J Gene Med 2019
64
15

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing.
Song Zhang, Jiangtao Shen, Dali Li, Yiyun Cheng. Theranostics 2021
54
15

Prime editing - an update on the field.
Janine Scholefield, Patrick T Harrison. Gene Ther 2021
19
15

Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing.
Tuo Wei, Qiang Cheng, Lukas Farbiak, Daniel G Anderson, Robert Langer, Daniel J Siegwart. ACS Nano 2020
29
15

The Biology of CRISPR-Cas: Backward and Forward.
Frank Hille, Hagen Richter, Shi Pey Wong, Majda Bratovič, Sarah Ressel, Emmanuelle Charpentier. Cell 2018
329
15

Viral Delivery Systems for CRISPR.
Christine L Xu, Merry Z C Ruan, Vinit B Mahajan, Stephen H Tsang. Viruses 2019
82
15

In vivo genome editing using Staphylococcus aureus Cas9.
F Ann Ran, Le Cong, Winston X Yan, David A Scott, Jonathan S Gootenberg, Andrea J Kriz, Bernd Zetsche, Ophir Shalem, Xuebing Wu, Kira S Makarova,[...]. Nature 2015
15

All-In-One Dendrimer-Based Lipid Nanoparticles Enable Precise HDR-Mediated Gene Editing In Vivo.
Lukas Farbiak, Qiang Cheng, Tuo Wei, Ester Álvarez-Benedicto, Lindsay T Johnson, Sang Lee, Daniel J Siegwart. Adv Mater 2021
16
18

High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population.
Dimitrios L Wagner, Leila Amini, Desiree J Wendering, Lisa-Marie Burkhardt, Levent Akyüz, Petra Reinke, Hans-Dieter Volk, Michael Schmueck-Henneresse. Nat Med 2019
182
15

Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.
Cody S Lee, Elliot S Bishop, Ruyi Zhang, Xinyi Yu, Evan M Farina, Shujuan Yan, Chen Zhao, Zongyue Zheng, Yi Shu, Xingye Wu,[...]. Genes Dis 2017
253
15

Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain.
Saed Abbasi, Satoshi Uchida, Kazuko Toh, Theofilus A Tockary, Anjaneyulu Dirisala, Kotaro Hayashi, Shigeto Fukushima, Kazunori Kataoka. J Control Release 2021
17
17

Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing.
Qiang Cheng, Tuo Wei, Lukas Farbiak, Lindsay T Johnson, Sean A Dilliard, Daniel J Siegwart. Nat Nanotechnol 2020
297
15

Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.
Nicole M Gaudelli, Alexis C Komor, Holly A Rees, Michael S Packer, Ahmed H Badran, David I Bryson, David R Liu. Nature 2017
15

Highly efficient Cas9-mediated transcriptional programming.
Alejandro Chavez, Jonathan Scheiman, Suhani Vora, Benjamin W Pruitt, Marcelle Tuttle, Eswar P R Iyer, Shuailiang Lin, Samira Kiani, Christopher D Guzman, Daniel J Wiegand,[...]. Nat Methods 2015
782
15

VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9.
Claudia Montagna, Gianluca Petris, Antonio Casini, Giulia Maule, Gian Marco Franceschini, Ilaria Zanella, Luciano Conti, Francesca Arnoldi, Oscar R Burrone, Lorena Zentilin,[...]. Mol Ther Nucleic Acids 2018
53
15

Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection.
Xiquan Liang, Jason Potter, Shantanu Kumar, Yanfei Zou, Rene Quintanilla, Mahalakshmi Sridharan, Jason Carte, Wen Chen, Natasha Roark, Sridhar Ranganathan,[...]. J Biotechnol 2015
395
15

AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Ang Li, Mark R Tanner, Ciaran M Lee, Ayrea E Hurley, Marco De Giorgi, Kelsey E Jarrett, Timothy H Davis, Alexandria M Doerfler, Gang Bao, Christine Beeton,[...]. Mol Ther 2020
73
15

Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3.
Min Qiu, Zachary Glass, Jinjin Chen, Mary Haas, Xin Jin, Xuewei Zhao, Xuehui Rui, Zhongfeng Ye, Yamin Li, Feng Zhang,[...]. Proc Natl Acad Sci U S A 2021
51
15

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells.
Yanfang Fu, Jennifer A Foden, Cyd Khayter, Morgan L Maeder, Deepak Reyon, J Keith Joung, Jeffry D Sander. Nat Biotechnol 2013
15

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes.
Luke A Gilbert, Matthew H Larson, Leonardo Morsut, Zairan Liu, Gloria A Brar, Sandra E Torres, Noam Stern-Ginossar, Onn Brandman, Evan H Whitehead, Jennifer A Doudna,[...]. Cell 2013
15

Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins.
Philippe E Mangeot, Valérie Risson, Floriane Fusil, Aline Marnef, Emilie Laurent, Juliana Blin, Virginie Mournetas, Emmanuelle Massouridès, Thibault J M Sohier, Antoine Corbin,[...]. Nat Commun 2019
95
15

Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing.
Pavel I Ortinski, Bernadette O'Donovan, Xiaoyu Dong, Boris Kantor. Mol Ther Methods Clin Dev 2017
67
15

Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease.
Naoya Uchida, Claire M Drysdale, Tina Nassehi, Jackson Gamer, Morgan Yapundich, Julia DiNicola, Yoshitaka Shibata, Malikiya Hinds, Bjorg Gudmundsdottir, Juan J Haro-Mora,[...]. Mol Ther Methods Clin Dev 2021
12
25

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Daniel Rosenblum, Anna Gutkin, Ranit Kedmi, Srinivas Ramishetti, Nuphar Veiga, Ashley M Jacobi, Mollie S Schubert, Dinorah Friedmann-Morvinski, Zvi R Cohen, Mark A Behlke,[...]. Sci Adv 2020
80
15

Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.
Ji Liu, Jin Chang, Ying Jiang, Xiandi Meng, Tianmeng Sun, Lanqun Mao, Qiaobing Xu, Ming Wang. Adv Mater 2019
119
15

High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Benjamin P Kleinstiver, Vikram Pattanayak, Michelle S Prew, Shengdar Q Tsai, Nhu T Nguyen, Zongli Zheng, J Keith Joung. Nature 2016
15

Fluorinated Acid-Labile Branched Hydroxyl-Rich Nanosystems for Flexible and Robust Delivery of Plasmids.
Yu Qi, Haiqing Song, Haihua Xiao, Gang Cheng, Bingran Yu, Fu-Jian Xu. Small 2018
36
15

HPV Oncogene Manipulation Using Nonvirally Delivered CRISPR/Cas9 or Natronobacterium gregoryi Argonaute.
Yeh-Hsing Lao, Mingqiang Li, Madeleine A Gao, Dan Shao, Chun-Wei Chi, Dantong Huang, Syandan Chakraborty, Tzu-Chieh Ho, Weiqian Jiang, Hong-Xia Wang,[...]. Adv Sci (Weinh) 2018
44
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.